Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically

Status Active, not recruiting

Clinical Trial Summary

This randomized pilot research trial studies how well Eat, Move, Live (EML) works in reducing chronic disease risk in medically vulnerable communities. Obesity, unhealthy diet, and physical inactivity are linked to increased cancer risk, especially hormone-related cancer (example, breast cancer). Improving healthy lifestyle practices, namely increasing physical activity and encouraging healthy eating behaviors may reduce the risk of getting cancer and chronic disease.

Clinical Trial Description

PRIMARY OBJECTIVES: I. Level of exercise. II. Reduction in barriers to exercise. III. Level of self-reported 5-9 servings of fruits and vegetables consumption. IV. Reduction in barriers to fruit and vegetable consumption. V. Improvement in biologic/metabolic markers such as hemoglobin A1c, fasting plasma glucose, and body weight. OUTLINE: Participants are randomized to 1 of 2 groups. GROUP I: Participants complete an assessment on knowledge, attitudes, and behaviors at baseline and attend 2 weekday sessions comprised of interactive education segment that is culturally responsive, and based on the community EML program, and topics including: nutrition guideline, nutrition label reading, comparison shopping/grocery store tour, recipe modification and healthy food preparation, eating healthy on a budget, and making healthy choices outside the home (e.g., restaurants) and physical activity over 1 hour led by Certified Health Educator (CHE), a physical activity conducted by Duarte Fitness Centers instructors over 30 minutes, and cooking/taste test demonstration co-led by the CHE and local chef over 30 minutes over 12 weeks. Participants are also prescribed and encouraged to participate in 3 days a week exercise classes (for > 30 minutes) including salsa, Zumba and other aerobic exercises that are provided at Duarte Fitness Center. GROUP II: Participants receive a fitness tracker to track their physical activity and be wait listed to receive the intervention during month 10-12. After completion of study, participants are followed up immediately and at 3 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02513407
Study type	Interventional
Source	City of Hope Medical Center
Contact
Status	Active, not recruiting
Phase	N/A
Start date	April 6, 2016
Completion date	December 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02664883` - Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
Completed	`NCT05611281` - GS3-007a Oral Solution in Healthy Subjects	Phase 1
Completed	`NCT03457480` - Text Messages in Preventing Tobacco Use in Young Adults	N/A
Completed	`NCT05358756` - A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers	Phase 1
Completed	`NCT06037395` - Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects	Phase 1
Active, not recruiting	`NCT04032106` - HPV Vaccine Intervention for Young Sexual Minority Men	N/A
Completed	`NCT04062955` - Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants	N/A
Recruiting	`NCT03897270` - Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects	N/A
Completed	`NCT01846520` - Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers	N/A
Completed	`NCT02960100` - mHealth Intervention in Increasing HPV Vaccinations in College Students	N/A
Completed	`NCT03698318` - Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts	N/A
Completed	`NCT05497635` - A Study of STSA-1002 in Healthy Subjects	Phase 1
Active, not recruiting	`NCT03303846` - Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients	N/A
Terminated	`NCT05559125` - A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects	Phase 1
Completed	`NCT03584100` - Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal	N/A
Recruiting	`NCT05117385` - The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)	N/A
Active, not recruiting	`NCT05660720` - Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects	Phase 1
Recruiting	`NCT03188848` - Dose Escalating Study of BPI-3016 in Healthy Subjects	Phase 1
Completed	`NCT01908920` - Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects	N/A
Active, not recruiting	`NCT03491176` - Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Eat, Move, Live Intervention in Reducing Chronic Disease Risk in Medically Vulnerable Communities

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms